Cann American Corp.

CNNA

US13764N2071

Pharmaceuticals

Market Closed - OTC Markets Other stock markets 01:29:54 11/05/2024 am IST			5-day change	1st Jan Change
0.003 ^USD	+50.00%		+25.00%	-25.00%

2023	Cann American Corp. Reports Earnings Results for the Full Year Ended February 28, 2023	CI
2023	Cann American Corp. Auditor Raises 'Going Concern' Doubt	CI

Cann American Corp. Reports Earnings Results for the Full Year Ended February 28, 2023

June 15, 2023 at 12:54 am IST

Cann American Corp. reported earnings results for the full year ended February 28, 2023. For the full year, the company reported net income was USD 3.82 million compared to USD 10.54 million a year ago.

Basic earnings per share from continuing operations was USD 0.01 compared to USD 0.04 a year ago.

Latest news about Cann American Corp.

Cann American Corp. Reports Earnings Results for the Full Year Ended February 28, 2023	15/23/15	CI
Cann American Corp. Auditor Raises 'Going Concern' Doubt	14/23/14	CI
Cann American Corp. Appoints Michael G. Kramer as a Director	17/23/17	CI
Cann American Corp. completed the acquisition of acquire Liberty Health Plus.	10/23/10	CI
Cann American Corp. entered into a letter of intent to acquire Liberty Health Plus.	01/23/01	CI
Cann American Corp. Appoints Peter Caruso as Director	16/23/16	CI
Cann American Corp. acquired Prodigy Stem Cell, LLC.	16/23/16	CI
Cann American Corp. Announces Board and Executive Changes	06/23/06	CI
Cann American Corp. Announces CEO Changes	06/23/06	CI
Cann American Corp. Reinstates Jason Black as CEO	26/23/26	CI
Cann American Corp. Announces Executive Changes	26/23/26	CI
Cann American Corp. has entered into an additional binding letter of intent to acquire 75% equity in Valkyrie Systems Inc.	09/22/09	CI
Cann American Corp. Appoints Alexander Woods-Leo as CEO	02/22/02	CI
Cann American Corp. Announces Management Changes	02/22/02	CI
Cann American Corp. completed the acquisition of 80% stake in Mark2media Group LLC.	31/22/31	CI
Cann American Corp. entered into a binding letter of intent to acquire 80% stake in Mark2media Group LLC.	26/22/26	CI
Cann American Corp. Accepts the Resignation of Bradley Hanger as Director	25/22/25	CI
Cann American Corp. acquired Hourglass Enterprises LLC.	12/21/12	CI
Fly Beverage Corp. announced that it expects to receive funding from Cann American Corp.	04/20/04	CI
Canamed4Pets, Inc. will Change its Name to Cann American Corp	20/19/20	CI
Cann American Corp. entered into an agreement to acquire Cannequipt, LLC from Patrick King for $0.04 million.	21/19/21	CI
Bioflamex Corporation has Changed its Ticker to BFLXD from BFLX	04/14/04	CI
Bioflamex Corp. Introduces Emergency Escape System	10/13/10	CI
Terra Asset Management, Inc. cancelled the acquisition of Bioflamex Corporation in a reverse merger transaction.	17/12/17	CI
Bioflamex Corporation will Change its Ticker to BFLXE from BFLX	19/12/19	CI

Chart Cann American Corp.

Duration

Period

More charts

Company Profile

Cann American Corp. is a holding company. The Company is engaged in developing assets within the legal cannabis and hemp industries. The Company has two subsidiaries, Cannequipt, LLC and Hourglass Enterprises LLC. Cannequipt, LLC, intends to act as a research and development division. Hourglass Enterprises LLC, intends to focus on developing new assets in the state of Oklahoma. The Company primarily within the state of California.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
CANN AMERICAN CORP.	-25.00%	2.21M
ELI LILLY AND COMPANY	+30.38%	684B
NOVO NORDISK A/S	+26.51%	568B
JOHNSON & JOHNSON	-4.36%	361B
MERCK & CO., INC.	+19.30%	329B
ABBVIE INC.	+3.73%	284B
ASTRAZENECA PLC	+16.70%	240B
NOVARTIS AG	+8.78%	208B
ROCHE HOLDING AG	-7.93%	200B
AMGEN INC.	+7.68%	166B

Other Pharmaceuticals